VALSARTAN/HYDROCHLOROTHIAZIDE RATIOPHARM 320 mg / 12.5 mg tabletti, kalvopäällysteinen Finlândia - finlandês - Fimea (Suomen lääkevirasto)

valsartan/hydrochlorothiazide ratiopharm 320 mg / 12.5 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - valsartanum,hydrochlorothiazidum - tabletti, kalvopäällysteinen - 320 mg / 12.5 mg - valsartaani ja diureetit

CANDESARTAN/HYDROCHLOROTHIAZIDE TEVA 32 mg / 25 mg tabletti Finlândia - finlandês - Fimea (Suomen lääkevirasto)

candesartan/hydrochlorothiazide teva 32 mg / 25 mg tabletti

teva pharma b.v. - candesartanum cilexetilum,hydrochlorothiazidum - tabletti - 32 mg / 25 mg - kandesartaani ja diureetit

CANDESARTAN/HYDROCHLOROTHIAZIDE STADA 16 mg / 12.5 mg tabletti Finlândia - finlandês - Fimea (Suomen lääkevirasto)

candesartan/hydrochlorothiazide stada 16 mg / 12.5 mg tabletti

stada arzneimittel ag - candesartanum cilexetilum,hydrochlorothiazidum - tabletti - 16 mg / 12.5 mg - kandesartaani ja diureetit

TELMISARTAN/HYDROCHLOROTHIAZIDE SANDOZ 40 mg / 12.5 mg tabletti, päällystetty Finlândia - finlandês - Fimea (Suomen lääkevirasto)

telmisartan/hydrochlorothiazide sandoz 40 mg / 12.5 mg tabletti, päällystetty

sandoz a/s sandoz a/s - telmisartanum,hydrochlorothiazidum - tabletti, päällystetty - 40 mg / 12.5 mg - telmisartaani ja diureetit

TELMISARTAN/HYDROCHLOROTHIAZIDE SANDOZ 80 mg / 25 mg tabletti, päällystetty Finlândia - finlandês - Fimea (Suomen lääkevirasto)

telmisartan/hydrochlorothiazide sandoz 80 mg / 25 mg tabletti, päällystetty

sandoz a/s sandoz a/s - telmisartanum,hydrochlorothiazidum - tabletti, päällystetty - 80 mg / 25 mg - telmisartaani ja diureetit

TELMISARTAN/HYDROCHLOROTHIAZIDE MYLAN 40 mg / 12.5 mg tabletti Finlândia - finlandês - Fimea (Suomen lääkevirasto)

telmisartan/hydrochlorothiazide mylan 40 mg / 12.5 mg tabletti

mylan ab - telmisartanum,hydrochlorothiazidum - tabletti - 40 mg / 12.5 mg - telmisartaani ja diureetit

TELMISARTAN/HYDROCHLOROTHIAZIDE RATIOPHARM 80 mg / 25 mg tabletti Finlândia - finlandês - Fimea (Suomen lääkevirasto)

telmisartan/hydrochlorothiazide ratiopharm 80 mg / 25 mg tabletti

ratiopharm gmbh - telmisartanum,hydrochlorothiazidum - tabletti - 80 mg / 25 mg - telmisartaani ja diureetit

Lisinopril/Hydrochlorothiazide Orion 20 mg / 12.5 mg tabletti Finlândia - finlandês - Fimea (Suomen lääkevirasto)

lisinopril/hydrochlorothiazide orion 20 mg / 12.5 mg tabletti

orion corporation - hydrochlorothiazide, lisinopril dihydrate - tabletti - 20 mg / 12.5 mg - lisinopriili ja diureetit

Sitagliptin / Metformin hydrochloride Mylan União Europeia - finlandês - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. kolmen lääkkeen yhdistelmähoito) lisänä ruokavalion ja liikunnan ohella potilaille riittävästi hallinnassa heidän maksimaalinen siedetty annos metformiinia ja sulfonyyliureaa. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin / Metformin hydrochloride Accord União Europeia - finlandês - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).